Research on Influencing Factors of Percutaneous Coronary Stent Implantation by Group Settlement Based on CHS-DRG
- VernacularTitle:基于CHS-DRG的经皮冠状动脉支架植入按病组结算影响因素研究
- Author:
Bozhao YANG
1
;
Youli HAN
;
Haiyang MA
;
Qian GENG
;
Wenbin WEI
Author Information
1. 首都医科大学附属北京同仁医院 北京 100730
- Keywords:
Diagnosis Related Groups;
percutaneous coronary stent implantation;
settlement method
- From:
Chinese Hospital Management
2023;43(12):20-24,28
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the data of percutaneous coronary stent implantation related groups in certain hospi-tal of Beijing,so as to provide data support for promoting CHS-DRG payment reform and provide guidance and reference for its refined management.Methods The case data of local medical insurance patients in Beijing who received percutaneous coronary stent implantation from January 2020 to December 2021 in certain hospital were statistically analyzed,collect the medical insurance settlement information of the selected patients,and analyze the factors that affect their entry into FM19 group settlement.Results There are differences in the factors affecting FM19 inclusion in different reform stages,overtransfer personnel is a new independent factor that interferes with the group settlement in the actual operation stage.Some special operation codes may interfere with cases entering FM19 group due to pri-ority effect among disease groups.Conclusion The grouping settlement conditions of CHS-DRG are more complex,patients with different expense types need to be specifically analyzed according to the current grouping scheme and reimbursement policy.At present,there are relatively few disease groups settled by package for urban residents,and they continue to be affected by the rule of grouping priority.However,it is necessary to fully implement and strengthen the cost control of disease groups for urban employees,and rationally optimize the diagnosis and treat-ment plan to finely control medical costs.
